When such tumours are cancerous, they often result in low-risk malignancies; however, less frequently, PTEN mutations have been detected in poorly differentiated thyroid carcinomas (PDTCs) and anaplastic thyroid carcinomas (ATCs) [20,21,22,23,24]. This evidence concerns the gene PTEN and neoplasm.